Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2002
07/03/2002EP1218353A1 Quinazoline derivatives
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP0860433B1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
07/03/2002EP0795548B1 Quinazoline derivatives and use thereof
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/03/2002CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof
07/03/2002CN1356989A Substituted herbicidal phenyluracils
07/03/2002CN1356988A Phenoxy fluoropyrimidines
07/03/2002CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands
07/02/2002USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/02/2002US6414149 Treating diabetes, treating or preventing diabetic complications
07/02/2002US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals
07/02/2002US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/02/2002US6413911 Reacting a sulfonyl isocyanate with a 2-amino-1,3,5-triazine or 2-aminopyrimidine, or reacting a sulfonamide with a phenyl carbamate or isocyanate of -1,3,5-triazine or pyridine
07/02/2002US6413724 Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
07/02/2002US6413503 Use of cyclic enamines as light protection agents
06/2002
06/27/2002WO2002050298A1 Method for the continuous biotechnological production of compatible solutes from toxic substrates
06/27/2002WO2002050064A1 Substituted pyrrolidines as ccr-3 receptor antagonists
06/27/2002WO2002050043A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
06/27/2002WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2002008201A3 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4
06/27/2002US20020082271 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
06/27/2002US20020082268 Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
06/27/2002US20020082265 For treating or preventing emphysema, cancer and dermatological disorders
06/27/2002US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins
06/27/2002US20020082218 Certain thiol inhibitors of endothelin-converting enzyme
06/27/2002US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects
06/27/2002US20020081339 Biodegradable microspheres releasing an anticancer agent are injected into the tumor, into the peritumoral area or both at the same time
06/27/2002CA2431767A1 Substituted pyrrolidines as ccr-3 receptor antagonists
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216980A1 Carboxylic acid derivatives and drugs containing the same
06/26/2002EP1216248A2 Triazolopyrimidine derivatives
06/26/2002EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
06/26/2002EP1216243A1 Quinazolinones and analogues and their use as local anesthetics
06/26/2002EP1216242A1 Macrocyclic quinazolinones and their use as local anesthetics
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP1216235A1 Quinazolinones
06/26/2002EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
06/26/2002EP1216233A1 Quinazolinones
06/26/2002EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function
06/26/2002EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
06/26/2002EP1007011A4 Lock and key micelles
06/26/2002EP0931067B1 D4 receptor selectivity piperazine derivatives
06/26/2002EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists
06/26/2002CN1355792A process for preparation of substituted pyrimidines
06/26/2002CN1355791A Process for production of 2-pyridylpyridine derivatives
06/26/2002CN1355713A Releasable bond and composition containing said bond
06/26/2002CN1355164A 3-(2-fluo-4,5,6-substituted phenyl)-1,3-quinazoline-2,4-dione compound with herbiciding activity
06/26/2002CN1355163A 3-(2-fluo-4,5,6-substituted phenyl)-1,3-benzopyrimidine-4-one compound with herbiciding activity
06/26/2002CN1086578C Sulfonamides and their use
06/25/2002US6410730 Preparing n-pyridylsulfonyl-n'-pyrimidinylurea sodium and potassium salts by reacting a pyridylsulfonamide salt with a pyrimidinyl isocyanate, or a pyridylsulfochloride with a pyrimidinylurea salt
06/25/2002US6410729 Substituted pyrimidine compounds and methods of use
06/25/2002US6410586 Modulators of protein tyrosine phosphatases (PTPases)
06/25/2002US6410580 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/25/2002US6410545 Lipid lowering quinazoline dietary supplement composition
06/25/2002US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/25/2002US6410484 6-Hydroxy-5,6-dihydrouracil compound and herbicidal composition containing thereof
06/25/2002US6410483 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
06/25/2002CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
06/21/2002WO2001047894A1 Substituted benzoylcyclohexane diones for use as herbicides
06/21/2002CA2406962A1 Substituted benzoylcyclohexane diones for use as herbicides
06/20/2002WO2002048137A2 Substituted heterocyclic phthalic acid diamide arthropodicides
06/20/2002WO2002048117A1 Quinazolinone derivatives
06/20/2002WO2002048115A2 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
06/20/2002WO2002048100A2 Thiosulphonic s-esters as material protective agent
06/20/2002WO2002047690A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2001090102A3 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
06/20/2002WO2001030328A3 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
06/20/2002US20020077486 Platelet ADP receptor inhibitors
06/20/2002US20020077330 For therapy of tumoral diseases, diseases of the lungs and respiratory tract
06/20/2002US20020077271 Compounds and methods of use to treat infectious diseases
06/20/2002DE10061541A1 New arylamino-substituted dihydropyrimidinone derivatives, useful as broad-spectrum antibacterial agents with strong activity against Gram positive bacteria
06/20/2002DE10061538A1 New ureido-substituted dihydropyrimidinone derivatives, useful as broad-spectrum antibacterial agents with strong activity against Gram positive bacteria
06/20/2002DE10061537A1 New beta-alanylamino-substituted dihydropyrimidinone derivatives, useful as antibacterial agents with strong activity against Gram positive bacteria, including methicillin-resistant Staphylococcus aureus
06/20/2002DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them
06/20/2002CA2431406A1 Quinazolinone derivatives
06/19/2002EP1215200A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
06/19/2002EP1214316A1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
06/19/2002EP1214303A1 Heterocyclic compounds and methods of use thereof
06/19/2002EP1214300A2 Rate-controlled particles
06/19/2002CN1354749A Use of selective antagonists of 1b-adrenergic receptor for improvement of sexual dysfunction
06/19/2002CN1086386C Multi-drug resistance modifier
06/18/2002US6407248 α-unsaturated amines, their production and use
06/18/2002US6407233 Halogen pyrimidines and its use thereof as parasite abatement means
06/18/2002US6407116 2,4-dioxo-1,2,3,4-tetrahydroquinazoline derivatives; antiallergens, antiasthmatics, antihistamines, and antiinflammatory agents
06/18/2002US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
06/13/2002WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/13/2002WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis